Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2
Chloé Najdek1, Pauline Walle1, Amandine Flaig1
1Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, Lille 59019, France.
Abstract:
The adapter protein KINDLIN2, encoded by the Alzheimer's disease (AD) genetic risk factor FERMT2, was identified as a modulator of APP processing. KINDLIN2 directly interacts with APP to modulate its metabolism, and KINDLIN2 underexpression impairs long-term potentiation in an APP-dependent manner. Altogether, these data suggest that loss of KINDLIN2 could have a detrimental effect on synaptic function and promote AD pathophysiological process. In this study, we identified KINDLIN2 as a novel substrate of caspases and calpain I, two well-characterized cysteine proteases involved in the regulation of synaptic plasticity. These cleavages resulted in the dissociation of the F0 and F1 domains of KINDLIN2 that are necessary for it to function as an adapter protein. Furthermore, we demonstrate that these cleavages lead to a decrease in KINDLIN2's ability to control APP processing. Overall, these KINDLIN2 cleavages appear as potential new mechanisms in the regulation of KINDLIN2 functions at the synapse and could be of interest for the pathophysiology of AD.
Insights
The adapter protein KINDLIN2, crucial for Alzheimer's disease (AD) pathology, is cleaved by caspases and calpain I. This cleavage impairs KINDLIN2's function in regulating amyloid precursor protein (APP) processing and synaptic plasticity.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- The adapter protein KINDLIN2, encoded by the Alzheimer's disease (AD) genetic risk factor FERMT2, modulates amyloid precursor protein (APP) processing.
- KINDLIN2 underexpression impairs long-term potentiation in an APP-dependent manner, suggesting its loss detrimentally affects synaptic function and promotes AD pathophysiology.
Purpose of the Study:
- To identify novel regulatory mechanisms of KINDLIN2 function at the synapse.
- To investigate the role of KINDLIN2 cleavage by caspases and calpain I in AD pathophysiology.
Main Methods:
- Identification of KINDLIN2 as a substrate for caspases and calpain I.
- Analysis of KINDLIN2 cleavage products and their impact on protein structure and function.
- Assessment of KINDLIN2's role in APP processing and synaptic plasticity.
Main Results:
- KINDLIN2 is a novel substrate of caspases and calpain I, cysteine proteases involved in synaptic plasticity.
- Cleavage by these proteases causes dissociation of KINDLIN2's F0 and F1 domains, essential for its adapter protein function.
- These cleavages decrease KINDLIN2's ability to regulate APP processing.
Conclusions:
- KINDLIN2 cleavage by caspases and calpain I represents a new regulatory mechanism for its synaptic function.
- These cleavage events may contribute to the pathophysiology of Alzheimer's disease by affecting APP processing and synaptic function.
More Related Videos
08:47Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Role of Matrix Metalloproteases in Degradation of ECM
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response
